Immunocore
IMCR
26.41
-0.22
-0.83%
Immunocore
US · IMCR
#2968 by market cap
Listed 2021
26.41
-0.22
-0.83%
Periodic snapshot; not a real-time feed.
· 2026-11-20 16:10
Recent news
-
Rating change
Needham Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $75Market Newswire · 2026/8/7
-
Rating change
Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Cuts Target Price to $33Market Newswire · 2026/10/29
-
Rating change
Oppenheimer Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $86Market Newswire · 2026/4/20
-
Rating change
J.P. Morgan Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $50Market Newswire · 2026/8/21
-
Rating change
TD Cowen Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/5/7
-
Rating change
Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $38Market Newswire · 2026/4/15
-
Rating change
Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $73Market Newswire · 2026/5/7
-
H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Cuts Target Price to $80Market Newswire · 2026/11/10
-
Rating change
Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Raises Target Price to $43Market Newswire · 2026/8/7
-
Rating change
Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Cuts Target Price to $34Market Newswire · 2026/5/8
-
Rating change
Immunocore Holdings (IMCR) Gets a Buy From H.C. WainwrightTipRanks · 2026/6/4
-
Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $43Market Newswire · 2026/11/9
-
Rating change
Goldman Sachs Maintains Immunocore(IMCR.US) With Buy RatingMarket Newswire · 2026/10/28
-
Rating change
H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100Market Newswire · 2026/11/5
-
Earnings Flash (IMCR) Immunocore Posts Q3 Loss $0.28 a Share, Vs. FactSet Est of $0.15 LossMT Newswires · 2026/11/6
-
Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Cuts Target Price to $42Market Newswire · 2026/11/13
-
Rating change
Wells Fargo Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/4/14
-
Rating change
Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $74Market Newswire · 2026/8/7
-
Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Announces Target Price $79Market Newswire · 2026/11/12
-
Rating change
Jefferies Initiates Immunocore(IMCR.US) With Hold Rating, Announces Target Price $33Market Newswire · 2026/3/16
-
Rating change
Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Cuts Target Price to $72Market Newswire · 2026/2/26
-
Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $43Market Newswire · 2026/10/22
-
Rating change
Needham Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $75Market Newswire · 2026/2/26
-
H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100Market Newswire · 2026/10/27
-
Rating change
Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $40Market Newswire · 2026/2/26
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 16:10:04 · For reference only, not investment advice and not tailored to your situation.
Immunocore discussion 0 comments